Cuba prepares 100 million doses of COVID vaccine ›Cuba› Granma
The Director General of the Finlay Vaccine Institute, Vicente VÃ©rez Bencomo, announced at a press conference with the participation of accredited foreign agencies that Cuba is creating the capacity to produce 100 million doses of the injectable vaccine Soberana 02 against COVID-19.
He reiterated that the goal was to meet the needs of the country as well as those of other countries interested in acquiring the vaccine, which so far include Vietnam, Iran, Venezuela, Pakistan and India. . In the case of our country, he said, the administration will be free, with the intention of vaccinating the entire population this year.
âCuba’s strategy to bring the vaccine to market has a combined goal of serving humanity and having an impact on global health. We are not a multinational, with the financial goal as the number one motivation. Our goal is to create more health, âsaid VÃ©rez Bencomo, Prensa Latina reported.
The Soberana 02 vaccine began extended phase II clinical trials this week, increasing participation to 900 volunteers aged 19 to 80, while in February a new survey will be conducted among the pediatric population.
Dr VÃ©rez explained that after analyzing the results of this step, a third phase will follow. During this period, health authorities plan to include 150,000 people in vulnerable groups and residents of high-risk areas.